Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol PFKL contributors: mct - updated : 22-09-2015
HGNC name phosphofructokinase, liver
HGNC id 8876
DNA
TYPE functioning gene
STRUCTURE 27.35 kb     25 Exon(s)
10 Kb 5' upstream gene genomic sequence study
MAPPING cloned Y linked Y status confirmed
Map cen - TMEM1 - D21S1460 - PWP2H - C21orf33 - D21S141 - CBS - CRYAA - D21S112 - D21S25 - D21S1461 - PFKL PFKL - C21orf2 - D21S154 - D21S400 - D21S170 - D21S171 - D21S1903 - SUMO3 - ITGB2 - D21S1897 - ADARB1 - COL18A1 - SLC19A1 - D21S44 - D21S112 - COL6A1 - LSS - COL6A2 - PCNT2 - S100B - D21S1446 - qter
Authors Petersen (91), Delabar (92), Gardiner (92), Chumakov (92), Falik-Borenstein (92), Kudoh (97), Lapenta (98)
RNA
TRANSCRIPTS type messenger
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
25 - 3412 - 830 - -
22 - 2934 - 780 - -
EXPRESSION
Type
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Digestiveliver    
cell lineage
cell lines
fluid/secretion
at STAGE
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
mono polymer tetramer
HOMOLOGY
Homologene
FAMILY
CATEGORY enzyme
SUBCELLULAR LOCALIZATION     plasma membrane
    intracellular
intracellular,cytoplasm,cytosolic
basic FUNCTION
  • energy patway
  • glycolytic efficiency, which is important for the survival of cancer cells, depends primarily on the preferential expression of PFKL over the PFKM and PFKP isoforms
  • is modified with OGT in cancer cells, and glycosylation is increased specifically under conditions associated with tumorigenesis and tumor growth
  • PFKL glycosylation contributes to cell proliferation and tumor growth
  • catalyses the committed step of the glycolytic pathway by converting fructose-6-phosphate to fructose-1,6-bisphosphate
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    fructose metabolism
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • NXN, a thioredoxin-related oxidoreductase, is a novel interacting partner of PFKL
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s) PFKL
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    cancer  
    blocking PFKL glycosylation to enhance its activity and reset cellular metabolism toward normal cell growth could therefore provide a new strategy to combat cancer
    ANIMAL & CELL MODELS